These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37383547)

  • 1. Supervised administration of primaquine may enhance adherence to radical cure for
    Rahi M; Sirohi PR; Sharma A
    Lancet Reg Health Southeast Asia; 2023 Jun; 13():100199. PubMed ID: 37383547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.
    Drysdale M; Tan L; Martin A; Fuhrer IB; Duparc S; Sharma H
    Infect Dis Ther; 2023 Jan; 12(1):33-51. PubMed ID: 36378465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
    Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
    Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study.
    Rahmalia A; Poespoprodjo JR; Landuwulang CUR; Ronse M; Kenangalem E; Burdam FH; Thriemer K; Devine A; Price RN; Peeters Grietens K; Ley B; Gryseels C
    Malar J; 2023 May; 22(1):162. PubMed ID: 37210520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Host Genetic Polymorphisms on the Efficacy of the Radical Cure Malaria Drug Primaquine.
    Nain M; Mohan M; Sharma A
    Am J Trop Med Hyg; 2022 Jan; 106(3):764-767. PubMed ID: 35008050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial.
    Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN
    Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
    Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
    BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment.
    Leslie T; Rab MA; Ahmadzai H; Durrani N; Fayaz M; Kolaczinski J; Rowland M
    Trans R Soc Trop Med Hyg; 2004 Mar; 98(3):168-73. PubMed ID: 15024927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
    Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
    Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
    PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.
    Thriemer K; Bobogare A; Ley B; Gudo CS; Alam MS; Anstey NM; Ashley E; Baird JK; Gryseels C; Jambert E; Lacerda M; Laihad F; Marfurt J; Pasaribu AP; Poespoprodjo JR; Sutanto I; Taylor WR; van den Boogaard C; Battle KE; Dysoley L; Ghimire P; Hawley B; Hwang J; Khan WA; Mudin RNB; Sumiwi ME; Ahmed R; Aktaruzzaman MM; Awasthi KR; Bardaji A; Bell D; Boaz L; Burdam FH; Chandramohan D; Cheng Q; Chindawongsa K; Culpepper J; Das S; Deray R; Desai M; Domingo G; Duoquan W; Duparc S; Floranita R; Gerth-Guyette E; Howes RE; Hugo C; Jagoe G; Sariwati E; Jhora ST; Jinwei W; Karunajeewa H; Kenangalem E; Lal BK; Landuwulang C; Le Perru E; Lee SE; Makita LS; McCarthy J; Mekuria A; Mishra N; Naket E; Nambanya S; Nausien J; Duc TN; Thi TN; Noviyanti R; Pfeffer D; Qi G; Rahmalia A; Rogerson S; Samad I; Sattabongkot J; Satyagraha A; Shanks D; Sharma SN; Sibley CH; Sungkar A; Syafruddin D; Talukdar A; Tarning J; Ter Kuile F; Thapa S; Theodora M; Huy TT; Waramin E; Waramori G; Woyessa A; Wongsrichanalai C; Xa NX; Yeom JS; Hermawan L; Devine A; Nowak S; Jaya I; Supargiyono S; Grietens KP; Price RN
    Malar J; 2018 Jun; 17(1):241. PubMed ID: 29925430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    Nekkab N; Lana R; Lacerda M; Obadia T; Siqueira A; Monteiro W; Villela D; Mueller I; White M
    PLoS Med; 2021 Apr; 18(4):e1003535. PubMed ID: 33891582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
    Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
    PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.